NIA - 29 January 2023
Biochemistry & Nutrition
Easy

Mechanism of action of Insulin occurs through?

Appeared in: NIA - 29 January 2023

Explanation

  • Insulin binds to a specific receptor on the cell surface known as a receptor tyrosine kinase, which is a type of enzyme-linked receptor.
  • This binding activates the receptor's intrinsic tyrosine kinase enzyme activity, causing it to phosphorylate itself (autophosphorylation).
  • The activated receptor then phosphorylates and activates other intracellular enzymes, such as Insulin Receptor Substrates (IRS).
  • This initiates a downstream signaling cascade that orchestrates insulin's metabolic effects, making 'activation of intracellular enzymes' the primary mechanism.

Why Other Options Were Wrong

  • Option A: This is a downstream effect, not the primary mechanism. The activation of intracellular enzymes leads to the translocation of GLUT4 transporters to the cell membrane, which then changes the membrane's permeability to glucose.
  • Option C: This is the primary mechanism for steroid hormones (e.g., cortisol, estrogen) and thyroid hormones. These hormones cross the cell membrane and bind to intracellular receptors that directly regulate gene transcription.
  • Option D: This mechanism is characteristic of G-protein coupled receptors (GPCRs), which use small, non-protein molecules like cAMP, IP₃, or Ca²⁺ as messengers. Glucagon and epinephrine work this way. Insulin uses an enzyme-linked receptor, which is a different class.

Related Visual

Visual explanation — Related Visual
Clinical Relevance
  • Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Insulin Signal Transduction Pathway as background academic context rather than a clinical decision trigger.
  • Understanding insulin's mechanism is fundamental to managing diabetes mellitus. Insulin resistance, the hallmark of Type 2 diabetes, involves defects in this signaling pathway, leading to reduced glucose uptake by cells.
  • Many pharmacologic agents for diabetes are designed to improve insulin sensitivity or bypass defects in this pathway.
  • Insulin administration in a clinical setting, particularly intravenous insulin, can cause rapid shifts in potassium into cells (along with glucose), leading to hypokalemia. This is a direct consequence of the signaling cascade stimulating the Na⁺-K⁺ ATPase pump.
How to Approach the Question
  • First, identify the molecule in the question: Insulin is a peptide hormone.
  • Recall the major classes of hormone action: 1) Enzyme-linked receptors, 2) G-protein coupled receptors with second messengers, and 3) Intracellular receptors that regulate genes.
  • Associate specific hormone types with their mechanisms. Peptide hormones like insulin and growth factors typically use enzyme-linked receptors.
  • Evaluate the options based on this classification. 'Activation of intracellular enzymes' is the defining feature of the enzyme-linked receptor pathway used by insulin.
  • Eliminate other options by linking them to different hormone classes: 'Activation of genes' is for steroids/thyroid hormones, and 'Via secondary messenger' is for hormones like glucagon that use GPCRs.
Concept Tested & Keywords
  • Concept Tested: Insulin Signal Transduction Pathway
  • Stem keywords: Mechanism of action, Insulin
  • Lead-in keywords: occurs through

Question ID

QR6RhEmPpd8U1nwecfFuyq

Reference Book

E6 Pharmacology Katzung 16e p. 1167-1169

E6 Physiology Essentials Sembulingam 10e Part 2 p. 63-65

E6 Physiology Guyton 4SAE Part 3 p. 1-3

Practise the full NIA - 29 January 2023

Attempt every question from this paper in a timed mock, then review the full solution for each one.